Surgical Anatomy of the Upper Abdomen: Comparison
Please note this is a comparison between Version 3 by Beatrix Zheng and Version 2 by Beatrix Zheng.

Cytoreductive surgery (CRS) is the cornerstone of treating advanced ovarian cancer. Approximately 60–70% of patients with advanced ovarian cancer will have involvement in the upper abdomen or the supracolic compartment of the abdominal cavity. Though the involvement of this region results in poorer survival compared, complete cytoreduction benefits overall survival, making upper-abdominal cytoreduction an essential component of CRS for advanced ovarian cancer. The upper abdomen constitutes several vital organs and large blood vessels draped with the parietal or visceral peritoneum, common sites of disease in ovarian cancer. A surgeon treating advanced ovarian cancer should be well versed in upper-abdominal cytoreduction techniques, including diaphragmatic peritonectomy and diaphragm resection, lesser omentectomy, splenectomy with or without distal pancreatectomy, liver resection, cholecystectomy, and suprarenal retroperitoneal lymphadenectomy. Other procedures such as clearance of the periportal region, Glisson’s capsulectomy, clearance of the superior recess of the lesser sac, and Morrison’s pouch are essential as these regions are often involved in ovarian cancer. 

  • advanced ovarian cancer
  • cytoreductive surgery
  • upper-abdominal surgery

1. Introduction

This excerpt describes the surgical anatomy of the upper abdomen in the context of performing cytoreductive surgery for peritoneal cancer spread from ovarian cancer. Epithelial ovarian cancer (EOC) continues to be diagnosed in an advanced stage in over 70% of patients, and approximately 60–70% of these patients will have involvement in the upper abdomen or the supracolic compartment of the abdominal cavity [1][2][3]. Over time, upper-abdominal cytoreductive surgery (CRS) has become an essential component of the skill set of surgical and gynecological oncologists treating advanced EOC [4][5]. The most common surgical procedures to clear the tumor from the upper abdomen include diaphragmatic peritonectomy and diaphragm resection, lesser omentectomy, splenectomy with or without distal pancreatectomy, liver resection, cholecystectomy, and suprarenal retroperitoneal lymphadenectomy. Other procedures such as clearance of the periportal region, Glisson’s capsulectomy, clearance of the superior recess of the lesser sac, and Morrison’s pouch are essential as these regions are often involved in ovarian cancer [6].
Advanced EOC is a peritoneal disease that often has a miliary or plaque-like morphology and is not detected on preoperative imaging [7]. A thorough exploration of the abdominal cavity to identify all disease sites is essential to avoid missing disease in some areas and thus perform what could be termed a ‘pseudo-complete’ cytoreduction [8][9]. There is limited information about the patterns of peritoneal dissemination or disease distribution in the scientific literature, which increases the dependence on surgical exploration and visual inspection performed during surgery [10]. The upper abdomen, in particular, could be challenging to explore for surgeons unfamiliar with the anatomy.

2. Surgical Anatomy of the Upper Abdomen

The upper abdomen could be defined in two ways. Considering the anatomy of the peritoneal cavity and its spaces, the supracolic compartment could be regarded as the ‘upper abdomen’ [11]. The peritoneal cancer index devised by Paul Sugarbaker divides the abdominal cavity into 13 anatomical regions, of which regions 1, 2, and 3 could jointly be considered the upper-abdominal regions [12].

2.1. Peritoneal Ligaments and Spaces

The upper-abdominal cavity or supracolic compartment comprises several ligaments and spaces [13]. The falciform and triangular ligaments are the suspensory ligaments of the liver that bind the bare area. The hepatoduodenal ligament (containing the common bile duct, hepatic artery, and portal vein) and the gastrohepatic ligament (which includes the left gastric artery and the coronary vein) form the lesser omentum [13]. The gastrosplenic ligament connects the greater curve of the stomach to the spleen and contains the short gastric vessels. The splenorenal ligament has the pancreatic tail. Ovarian cancer could involve any of these structures and the surgeon should be familiar with their anatomy.
The supramesocolic compartment is divided into the left and right subphrenic spaces by the falciform ligament on the anterior aspect of the liver. The sub-hepatic space, including the lesser sac, is located under the liver. The right subphrenic space is located under the right diaphragm; it communicates inferiorly with the right paracolic space and is separated from the left subphrenic space by the falciform ligament [14]. The right sub-hepatic space continues medially through the foramen of Winslow (Epiploic foramen) to the lesser sac (Bursa Omentalis) [14].
The lesser sac is a potentially large cavity with various recesses communicating with the left subphrenic space cranially and into the greater omentum caudally. The lesser sac contains a superior recess (located above the peritoneal reflection of the left gastric artery) close to the caudate lobe and a larger inferior recess between the stomach and the pancreatic body. The superior and inferior recesses are separated by a peritoneal fold that accompanies the left gastric artery. Sometimes, the inferior recess communicates with a potential space between the leaves of the greater omentum [14].

2.2. Anatomical Boundaries from the Surgical Viewpoint

The peritoneal regions lying in each region and their boundaries are described in Table 1. More details can be found online in the PROMISE internet application (www.e-promise.org). [15]

2.3. Regional Nodes

Several nodal stations in the upper abdomen could be involved in advanced ovarian cancer. Some of these nodes are involved secondary to the primary tumor as part of retroperitoneal lymphadenopathy and these include the suprarenal retroperitoneal or paraaortic nodes such as the superior mesenteric and celiac axis nodes. The other nodes are the omental nodes along the lesser and greater curves, the left gastric nodes, periportal nodes, and pericardiac nodes. The supradiaphragmatic nodes often dissected during upper-abdominal cytoreduction include the sub-xiphoid or cardiophrenic angle nodes, costophrenic lymph nodes, and paracaval nodes [18]. It is unclear whether these nodal stations are regional nodes or distant metastases, as their involvement has not been classified in the TNM and FIGO classifications [19][20]. FigureFigure 1 1 shows the anatomical location of the supradiaphragmatic nodes (Figure 28 from the original article) .
Figure 1. The sub-xiphoid and transdiaphragmatic approaches for resecting supradiaphragmatic lymph nodes (adapted from [71] with permission).

References

  1. Doubeni, C.A.; Doubeni, A.R.; Myers, A.E. Diagnosis and Management of Ovarian Cancer. Am. Fam. Physician 2016, 93, 937–944.
  2. Healy, J.C.; Reznek, R.H. The peritoneum, mesenteries and omenta: Normal anatomy and pathological processes. Eur. Radiol. 1998, 8, 886–900.
  3. Pathiraja, P.N.; Garruto-Campanile, R.; Tozzi, R. Diaphragmatic peritonectomy versus full thickness diaphragmatic resection and pleurectomy during cytoreduction in patients with ovarian cancer. Int. J. Surg. Oncol. 2013, 2013, 876150.
  4. Eisenhauer, E.L.; Abu-Rustum, N.R.; Sonoda, Y.; Levine, D.A.; Poynor, E.A.; Aghajanian, C.; Jarnagin, W.R.; Chi, D.S.; Barakat, R.R.; DeMatteo, R.P.; et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol. Oncol. 2006, 103, 1083–1090.
  5. Eng, O.S.; Raoof, M.; Blakely, A.M.; Yu, X.; Lee, S.J.; Han, E.S.; Wakabayashi, M.T.; Yuh, B.; Lee, B.; Dellinger, T.H. A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer. J. Surg. Oncol. 2018, 118, 121–126.
  6. Meyers, M.A. Distribution of intra-abdominal malignant seeding: Dependency on dynamics of flow of ascitic fluid. Am. J. Roentgenol. Radium Ther. Nucl. Med. 1973, 119, 198–206.
  7. Pannu, H.K.; Bristow, R.E.; Montz, F.J.; Fishman, E.K. Multidetector CT of peritoneal carcinomatosis from ovarian cancer. Radiographics 2003, 23, 687–701.
  8. Martín-Cameán, M.; Delgado-Sánchez, E.; Piñera, A.; Diestro, M.D.; De Santiago, J.; Zapardiel, I. The role of surgery in advanced epithelial ovarian cancer. Ecancermedicalscience 2016, 10, 666.
  9. Bianchi, F.; Camargo, A.; Habich, D.; Castano, R. The fundamental role of the exploration of the upper abdomen in ovarian cancer surgery. Obstet. Gynecol. Int. J. 2021, 12, 337–342.
  10. Bhatt, A.; Parikh, L.; Mishra, S.; Glehen, O. Epithelial Serous Ovarian Cancer: Patterns of Peritoneal Dissemination and their Clinical Implications. In Pathology of Peritoneal Metastases; Glehen, O., Bhatt, A., Eds.; Springer: Singapore, 2020.
  11. Sharma, M.; Madambath, J.G.; Somani, P.; Pathak, A.; Rameshbabu, C.S.; Bansal, R.; Ramasamy, K.; Patil, A. Endoscopic ultrasound of peritoneal spaces. Endosc. Ultrasound. 2017, 6, 90–102.
  12. Jacquet, P.; Sugarbaker, P.H. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In Peritoneal Carcinomatosis: Principles of Management; Sugarbaker, P.H., Ed.; Kluwer: Boston, MA, USA, 1996; pp. 359–374.
  13. Meyers, M.A.; Charnsangavej, C.; Oliphant, M. Meyers’ Dynamic Radiology of the Abdomen, 6th ed.; Springer: New York, NY, USA, 2011; pp. 23–34.
  14. Kim, S.; Kim, T.U.; Lee, J.W.; Lee, T.H.; Lee, S.H.; Jeon, T.Y.; Kim, K.H. The perihepatic space: Comprehensive anatomy and CT features of pathologic conditions. Radiographics 2007, 27, 129–143.
  15. Villeneuve, L.; Thivolet, A.; Bakrin, N.; Mohamed, F.; Isaac, S.; Valette, P.J.; Glehen, O.; Rousset, P.; BIG-RENAPE and RENAPE Working Groups. A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application. Eur. J. Surg. Oncol. 2016, 42, 877–882.
  16. Sugarbaker, P.H. Peritonectomy procedures. Ann. Surg. 1995, 221, 29–42.
  17. Bhatt, A.; Mehta, S. Cytoreductive Surgery for Peritoneal Metastases: Principles and Techniques. In Management of Peritoneal Metastases-Cytoreductive Surgery, HIPEC and Beyond; Bhatt, A., Ed.; Springer: Singapore, 2018.
  18. Lee, I.O.; Lee, J.Y.; Kim, H.J.; Nam, E.J.; Kim, S.; Kim, S.W.; Lee, C.Y.; Kang, W.J.; Kim, Y.T. Prognostic significance of supradiaphragmatic lymph node metastasis detected by 18F-FDG PET/CT in advanced epithelial ovarian cancer. BMC Cancer 2018, 18, 1165.
  19. Berek, J.S.; Kehoe, S.T.; Kumar, L.; Friedlander, M. Cancer of the ovary, fallopian tube, and peritoneum. Int. J. Gynecol. Obstet. 2018, 143, 59–78.
  20. Buza, N. Staging. PathologyOutlines.com website. Available online: https://www.pathologyoutlines.com/topic/ovarytumorstage.html (accessed on 24 December 2021).
More
ScholarVision Creations